Caloro M, Lionetto L, Cuomo I, Simonetti A, Pucci D, De Persis S, Casolla B, Kotzalidis GD, Sciarretta A, De Filippis S, Simmaco M, Girardi P. An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite.
J Pharm Biomed Anal 2012;
62:135-9. [PMID:
22300908 DOI:
10.1016/j.jpba.2012.01.003]
[Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2011] [Revised: 01/04/2012] [Accepted: 01/05/2012] [Indexed: 11/26/2022]
Abstract
BACKGROUND AND OBJECTIVES
Current liquid chromatographic tandem mass spectrometry (LC-MS/MS) methods to measure serum levels of aripiprazole (Ar) and dehydroaripiprazole (DHAr) are sensitive, but difficult to use in a hospital context. We aimed to develop a rapid LC-MS/MS method allowing reliable level measurement in the presence of co-administered drugs, withdrawing samples from 22 patients with acute agitation receiving 9.75 mg aripiprazole IM injection.
METHOD
We developed a sensitive and selective HPLC-MS/MS method to measure serum Ar and DHAr levels in a hospital laboratory, requiring minimal sample preparation and inferior sample volume compared to previous LC-MS/MS methods. Analytes were separated on a reversed-phase HPLC (run-time, 10 min). A triple quadrupole tandem mass spectrometer was used for quantitative analysis in positive mode by a multiple reaction monitoring. Samples were drawn 2, 4, 6, and 24h post-injection.
RESULTS
Calibration curves (2-1000 ng/mL for Ar and 3.5-500 ng/mL for DHAr) were linear, with mean correlation coefficient >0.9998. Within- and between-day precision and accuracy were within 10%. Mean recovery was 95.2 ± 4.5% for Ar and 97.6 ± 7.2% for DHAr. Ar and DHAr peaks were not affected by other co-administered psychotropic drugs.
CONCLUSION
Our method measured Ar and DHAr concentrations reliably, simply and rapidly without employing many reagents, as currently existing methods.
Collapse